Researcher profile

Toshi A. Furukawa

Toshi A. Furukawa contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 13 - UnverifiedVerification L1Unclaimed author
2works
0followers
3topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2022arXiv

A dose-effect network meta-analysis model: an application in antidepressants

Network meta-analysis (NMA) has been used to answer a range of clinical questions about the preferable intervention for a given condition. Although the effectiveness and safety of pharmacological agents depend on the dose administered, NMA applications typically ignore the role that drugs dosage play on the results. This leads to more heterogeneity in the network. In this paper we present a suite of network meta-analysis models that incorporates the dose-effect relationship (DE-NMA) using restricted cubic splines (RCS). We extend the model into a dose-effect network meta-regression to account for study-level covariates and for groups of agents in a class-effect DE-NMA model. We apply the models to a network of aggregate data about the efficacy of 21 antidepressants and placebo for depression. We found that all antidepressants are more efficacious than placebo after a certain dose. We also identify the dose level in which each antidepressant effect exceeds that of placebo and estimate the dose beyond the effect of the antidepressants no longer increases. The DE-NMA model with RCS takes a flexible approach to modelling the dose-effect relationship in multiple interventions, so decision-makers can use them to inform treatment choice.

preprint2021arXiv

Confidence intervals of prediction accuracy measures for multivariable prediction models based on the bootstrap-based optimism correction methods

In assessing prediction accuracy of multivariable prediction models, optimism corrections are essential for preventing biased results. However, in most published papers of clinical prediction models, the point estimates of the prediction accuracy measures are corrected by adequate bootstrap-based correction methods, but their confidence intervals are not corrected, e.g., the DeLong's confidence interval is usually used for assessing the C-statistic. These naive methods do not adjust for the optimism bias and do not account for statistical variability in the estimation of parameters in the prediction models. Therefore, their coverage probabilities of the true value of the prediction accuracy measure can be seriously below the nominal level (e.g., 95%). In this article, we provide two generic bootstrap methods, namely (1) location-shifted bootstrap confidence intervals and (2) two-stage bootstrap confidence intervals, that can be generally applied to the bootstrap-based optimism correction methods, i.e., the Harrell's bias correction, 0.632, and 0.632+ methods. In addition, they can be widely applied to various methods for prediction model development involving modern shrinkage methods such as the ridge and lasso regressions. Through numerical evaluations by simulations, the proposed confidence intervals showed favourable coverage performances. Besides, the current standard practices based on the optimism-uncorrected methods showed serious undercoverage properties. To avoid erroneous results, the optimism-uncorrected confidence intervals should not be used in practice, and the adjusted methods are recommended instead. We also developed the R package predboot for implementing these methods (https://github.com/nomahi/predboot). The effectiveness of the proposed methods are illustrated via applications to the GUSTO-I clinical trial.